Catheter ablation of ventricular tachycardia in patients with structural heart disease

John Miller, Gregory T. Altemose, J. Vijay Jayachandran, Fred Morady

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Radiofrequency catheter ablation has revolutionized therapy of most forms of supraventricular tachycardia and ventricular tachycardia in the absence of structural heart disease by providing arrhythmia cure in almost 90% of patients. However, this treatment has not been nearly as successful in patients with ventricular tachycardia in the setting of structural heart disease, because of a number of factors. Some of these limitations are technical (imprecise mapping tools, multiple regions requiring ablation) although others are patient-related (hemodynamic instability during arrhythmia, progression of disease process). Because of these and other factors, the majority of patients in this group are treated with implantable defibrillators. Ablative therapy has an adjunctive role in their management, mainly to decrease the frequency of device therapy (particularly shocks). This review will discuss mapping and ablation techniques as well as patient selection and evaluation for this procedure.

Original languageEnglish
Pages (from-to)302-311
Number of pages10
JournalCardiology in Review
Volume9
Issue number6
StatePublished - 2001

Fingerprint

Catheter Ablation
Ventricular Tachycardia
Heart Diseases
Cardiac Arrhythmias
Ablation Techniques
Convulsive Therapy
Supraventricular Tachycardia
Implantable Defibrillators
Patient Selection
Disease Progression
Therapeutics
Hemodynamics
Equipment and Supplies

Keywords

  • Cardiomyopathy
  • Catheter ablation
  • Ventricular tachycardia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Miller, J., Altemose, G. T., Jayachandran, J. V., & Morady, F. (2001). Catheter ablation of ventricular tachycardia in patients with structural heart disease. Cardiology in Review, 9(6), 302-311.

Catheter ablation of ventricular tachycardia in patients with structural heart disease. / Miller, John; Altemose, Gregory T.; Jayachandran, J. Vijay; Morady, Fred.

In: Cardiology in Review, Vol. 9, No. 6, 2001, p. 302-311.

Research output: Contribution to journalArticle

Miller, J, Altemose, GT, Jayachandran, JV & Morady, F 2001, 'Catheter ablation of ventricular tachycardia in patients with structural heart disease', Cardiology in Review, vol. 9, no. 6, pp. 302-311.
Miller, John ; Altemose, Gregory T. ; Jayachandran, J. Vijay ; Morady, Fred. / Catheter ablation of ventricular tachycardia in patients with structural heart disease. In: Cardiology in Review. 2001 ; Vol. 9, No. 6. pp. 302-311.
@article{74ad60350bd14103b1a74d37ed8d220a,
title = "Catheter ablation of ventricular tachycardia in patients with structural heart disease",
abstract = "Radiofrequency catheter ablation has revolutionized therapy of most forms of supraventricular tachycardia and ventricular tachycardia in the absence of structural heart disease by providing arrhythmia cure in almost 90{\%} of patients. However, this treatment has not been nearly as successful in patients with ventricular tachycardia in the setting of structural heart disease, because of a number of factors. Some of these limitations are technical (imprecise mapping tools, multiple regions requiring ablation) although others are patient-related (hemodynamic instability during arrhythmia, progression of disease process). Because of these and other factors, the majority of patients in this group are treated with implantable defibrillators. Ablative therapy has an adjunctive role in their management, mainly to decrease the frequency of device therapy (particularly shocks). This review will discuss mapping and ablation techniques as well as patient selection and evaluation for this procedure.",
keywords = "Cardiomyopathy, Catheter ablation, Ventricular tachycardia",
author = "John Miller and Altemose, {Gregory T.} and Jayachandran, {J. Vijay} and Fred Morady",
year = "2001",
language = "English",
volume = "9",
pages = "302--311",
journal = "Cardiology in Review",
issn = "1061-5377",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Catheter ablation of ventricular tachycardia in patients with structural heart disease

AU - Miller, John

AU - Altemose, Gregory T.

AU - Jayachandran, J. Vijay

AU - Morady, Fred

PY - 2001

Y1 - 2001

N2 - Radiofrequency catheter ablation has revolutionized therapy of most forms of supraventricular tachycardia and ventricular tachycardia in the absence of structural heart disease by providing arrhythmia cure in almost 90% of patients. However, this treatment has not been nearly as successful in patients with ventricular tachycardia in the setting of structural heart disease, because of a number of factors. Some of these limitations are technical (imprecise mapping tools, multiple regions requiring ablation) although others are patient-related (hemodynamic instability during arrhythmia, progression of disease process). Because of these and other factors, the majority of patients in this group are treated with implantable defibrillators. Ablative therapy has an adjunctive role in their management, mainly to decrease the frequency of device therapy (particularly shocks). This review will discuss mapping and ablation techniques as well as patient selection and evaluation for this procedure.

AB - Radiofrequency catheter ablation has revolutionized therapy of most forms of supraventricular tachycardia and ventricular tachycardia in the absence of structural heart disease by providing arrhythmia cure in almost 90% of patients. However, this treatment has not been nearly as successful in patients with ventricular tachycardia in the setting of structural heart disease, because of a number of factors. Some of these limitations are technical (imprecise mapping tools, multiple regions requiring ablation) although others are patient-related (hemodynamic instability during arrhythmia, progression of disease process). Because of these and other factors, the majority of patients in this group are treated with implantable defibrillators. Ablative therapy has an adjunctive role in their management, mainly to decrease the frequency of device therapy (particularly shocks). This review will discuss mapping and ablation techniques as well as patient selection and evaluation for this procedure.

KW - Cardiomyopathy

KW - Catheter ablation

KW - Ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=0035182844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035182844&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 302

EP - 311

JO - Cardiology in Review

JF - Cardiology in Review

SN - 1061-5377

IS - 6

ER -